--- 
#Jekyll front matter 
layout: default 
title: Ethics of cancer treatment 
description: 
parent: sequence-two
module: three
---
<div class="content">
    <p class="sequence-title">Sequence 2: Cancer (target cells) <span style="font-style: normal; margin: 0 10px;">&rang;</span>  Module 3:</p>
    <h1>Ethics of cancer treatment</h1>
    <p class="intro">The third module within Sequence 2 focuses on identifying the ethical issues around the design and testing of contemporary cancer treatments.  It is possible that this module could take 3 hours of class time.</p>
    <h2>Summary</h2>
    <div class="col-2max module-info">
        <div>
            <h3>VCE Biology (2017-2021)</h3>
            <p>Unit 4, Area of Study 2, Outcome 2, <a class="new-tab-warning" href="http://www.vcaa.vic.edu.au/Documents/vce/biology/BiologySD-2016.pdf" target="_blank">VCE Biology Study Design</a></p>
            <h4>Key knowledge</h4>
            <p>Biological knowledge and society</p>
        </div>
        <div>
            <h3>Duration</h3>
            <p><img src="{{ site.baseurl }}/img/time.svg" alt="" class="clock"> 3 hours</p>
            <h3>Student learning outcomes</h3>
            <p>On completion of this module, students will:</p>
            <ul>
                <li>Identify the ethical issues around cancer drug design and delivery</li>
                <li>Analyse the interrelationship between scientific knowledge and its application in society</li>
                <li>Understand the social and ethical implications and issues surrounding CAR T-cell cancer treatments</li>
            </ul>
        </div>
    </div>
    <h2>Teacher background information</h2>
    <h3>Additional introductory resources</h3>
    <div class="resources col-3max flex">
        <div class="resource web">
            <div>
                <h5>Article</h5>
                <p><strong>Frameworks for Ethical analysis</strong></p>
                <div class="description">
                   
                </div>
                <a class="open" href="http://biotechlearn.org.nz/themes/bioethics/frameworks_for_ethical_analysis">Open</a>
            </div>
            <div class="overlay">
                <a class="open-new-tab" href="http://biotechlearn.org.nz/themes/bioethics/frameworks_for_ethical_analysis" target="_blank">Open in new tab</a>
            </div>
        </div>
        <div class="resource web">
            <div>
                <h5>Article</h5>
                <p><strong>Ethical dilemmas in fighting infection</strong></p>
                <div class="description">
                    <p>Note: this process is for some of the stories that the particular web site has focused on. The same process/concept could be used for the discussion of social and ethical implications around T cell therapy and other immunotherapies. Issues such as:</p>
                    <ul>
                        <li>Unknown side effects</li>
                        <li>Access to clinical trials</li>
                    </ul>
                </div>
                <a class="open" href="http://sciencelearn.org.nz/Contexts/Fighting-Infection/Teaching-and-Learning-Approaches/Ethical-dilemmas-in-fighting-infection">Open</a>
            </div>
            <div class="overlay">
                <a class="open-new-tab" href="http://sciencelearn.org.nz/Contexts/Fighting-Infection/Teaching-and-Learning-Approaches/Ethical-dilemmas-in-fighting-infection" target="_blank">Open in new tab</a>
            </div>
        </div>
    </div>
    <p>Thought: Fast-tracking therapies based on a small (but high percentage) of success rates.</p>  
    <p>Question:  CAR T-cell therapy is used for patients with end-stage cancer where other available treatments have failed.  If CAR T-cell therapy successfully ensures remission in a number of patients, why do we need so many clinical trials? Why canâ€™t the treatment be available to everyone?</p>
    <div class="resources col-3max flex">
        <div class="resource web">
            <div>
                <h5>Resource</h5>
                <p><strong>TES: Monoclonal Antibodies lesson</strong></p>
                <div class="description">
                   <p>Asks students to investigate the ethics of the use of animals in creating monoclonal 	antibodies, and the risks to humans in clinical trials of cancer treatments. Includes worksheets, presentation and a range of questions pertaining to ethics.</p>
                </div>
                <a class="open" href="https://www.tes.com/teaching-resource/monoclonal-antibodies-lesson-6426297">Open</a>
            </div>
            <div class="overlay">
                <a class="open-new-tab" href="https://www.tes.com/teaching-resource/monoclonal-antibodies-lesson-6426297" target="_blank">Open in new tab</a>
            </div>
        </div>
        <div class="resource web">
            <div>
                <h5>Resource</h5>
                <p><strong>TES Australia: Herceptin the story of a new medicine</strong></p>
                <div class="description">
                    <p>A powerpoint presentation that provides an outline on how the monoclonal antibody Herceptin is developed using animals. Can be used as a case study to discuss the ethics of cancer research.</p>
                </div>
                <a class="open" href="https://www.tes.com/teaching-resource/herceptin-the-story-of-a-new-medicine-6398942">Open</a>
            </div>
            <div class="overlay">
                <a class="open-new-tab" href="https://www.tes.com/teaching-resource/herceptin-the-story-of-a-new-medicine-6398942" target="_blank">Open in new tab</a>
            </div>
        </div>
    </div>
    <h2>Teaching sequence</h2>
    <div class="activity">
        <p>Activity 3.1</p>
        <p>Debate, write a letter to the editor or role play the following issue: <br><b>Identify the ethical issues around cancer drug design and delivery</b>.</p>
    </div>
</div>